论文部分内容阅读
经皮、经腔的肾血管成形术(percutaneous transluminal renal angioplasty,PTRA)是近年来发展起来的治疗肾动脉狭窄的新方法。本法较简便和安全,可避免较大的手术和全身麻醉,且能保留肾组织,治疗效果良好。现在治疗肾血管性高血压除传统的外科血管再形成术(surgical revascularization)和药物疗法外,许多学者已把PTRA作为第三种疗法。发展和技术的简介 PTRA是以经皮、经腔的血管成形术(PTA)为基础发展起来的,现已成为PTA的重要分枝。PTA是1964年由Dotter和Judkins发明,并应用于周围血管动脉粥样硬化疾病。
Percutaneous transluminal renal angioplasty (PTRA) is a new method for the treatment of renal artery stenosis developed in recent years. This method is relatively simple and safe, to avoid the larger surgery and general anesthesia, and can retain the renal tissue, the treatment effect is good. Treatment of Renal Vascular Hypertension In addition to traditional surgical revascularization and drug therapy, many scholars have already considered PTRA as the third treatment. Development and Technology Introduction PTRA is based on percutaneous, transluminal angioplasty (PTA) and has become an important branch of PTA. PTA was invented by Dotter and Judkins in 1964 and applied to peripheral vascular atherosclerotic diseases.